24 research outputs found
Malignant fibrous histiocytoma of the spermatic cord: a case report and review of the literature
Malignant fibrous histiocytoma (MFH) is a morphologically ill-defined tumour of
the soft tissues and may involve nearly every organ of the body. MFH of the
spermatic cord represents an extremely rare entity and reports of it in the literature
are limited. We report a 69-year-old man found to have a left spermatic
cord MFH and retroperitoneal and mediastinal lymphadenopathy, who was treated
with radical orchiectomy and adjuvant chemotherapy. The morphological
findings of the spermatic tumour are presented and the literature is reviewed to
clarify the potential diagnostic/therapeutic approaches and the prognosis related
to spermatic cord MFH
Life quality of cancer patient with or without self awareness
Background and Objective: Disclosure of cancer is one the main challenges in caring of patients with cancer, since it may have adverse effects on the patients quality of life. This study was done to determine life quality of cancer patient with or without self awareness. Materials and Methods: This case â control study was conducted on 300 cancer patients in Shahid Ghazi-Tabatabaei hospital in Tabriz, Iran during 2009. The cancer patients included 150 subjects aware of their cancer diagnosis as cases and 150 unaware patients as controls. The patient's quality of life was assessed Using EORTC QLQ-C30 questionnaire. Data were analyzed using SPSS-17 and studentâs t-test. Results: The mean±SD of quality of life among aware and unaware patients were 64.18±18.85 and 65.16±19.02, respectively. There was no significant difference of quality of life between two groups. Life social dimension in unaware patients significantly was more than aware patients (P<0.05). Conclusion: Patients awareness of cancer have no effect on their quality of life
Chemotherapy-induced amenorrhea in patients suffering from breast cancer in the Northwest of Iran
Ameliorative Effects of Hydroalcoholic Extract of Lavandula officinalis L. on Methotrexate-Induced Oxidative Stress in Rats
Age pattern of the occurrence of breast cancer in the northwest of Iran
Breast cancer represents 27% of the cancers and 19% of the cancer
deaths in female population. The aim of this study was to document the
age pattern of the incidence of breast cancer in Iranian female
population in the northwest region of the country. The study subjects
were 1764 patients with breast cancer diagnosed/registered in the six
university clinics between 1988 and 2008 in the northwest of Iran. The
highest occurrence rates were observed for the birth year cohorts
1940-1949 (for 59-69 years old), 1950-1959 (for 49-58 years old), and
1960-1969 (for 39-48 years old). Among these three cohorts, the highest
rate was observed in 1950-1959 birth year cohort (284.38 per 100,000
female populations, 95% CI: 260-310). This rate was significantly
higher compared with the similar rates of other birth cohorts. There
was no statistically significant difference between various years in
terms of the average age at the diagnosis of breast cancer in our study
setting. Despite the previous research reports, we found no significant
difference between the mean ages at diagnosis of breast cancer from
1988 to 2008 in Iranian female population
Diallyl disulfide ameliorates methotrexateâinduced nephropathy in rats: Molecular studies and network pharmacology analysis
Age pattern of the occurrence of breast cancer in the northwest of Iran
Breast cancer represents 27% of the cancers and 19% of the cancer
deaths in female population. The aim of this study was to document the
age pattern of the incidence of breast cancer in Iranian female
population in the northwest region of the country. The study subjects
were 1764 patients with breast cancer diagnosed/registered in the six
university clinics between 1988 and 2008 in the northwest of Iran. The
highest occurrence rates were observed for the birth year cohorts
1940-1949 (for 59-69 years old), 1950-1959 (for 49-58 years old), and
1960-1969 (for 39-48 years old). Among these three cohorts, the highest
rate was observed in 1950-1959 birth year cohort (284.38 per 100,000
female populations, 95% CI: 260-310). This rate was significantly
higher compared with the similar rates of other birth cohorts. There
was no statistically significant difference between various years in
terms of the average age at the diagnosis of breast cancer in our study
setting. Despite the previous research reports, we found no significant
difference between the mean ages at diagnosis of breast cancer from
1988 to 2008 in Iranian female population